Rene Tavernier

Variations of autonomic tone preceding onset of atrial fibrillation after coronary artery bypass grafting

Assessment of autonomic tone preceding the onset of atrial fibrillation (AF) after coronary artery bypass grafting (CABG) with heart rate variability was examined in 64 patients scheduled for elective CABG (days 2 to 5). Ninety-six-hour Holter tapes were analyzed in each patient and all events labeled by an experienced technician. The hour preceding AF was divided into 4 quarters (heart rate variability calculated per quarter) and compared with similar time episodes from the group without AF. Twenty-six of 64 patients (40%) had a total of 35 episodes. Only increased age (68+/-5 vs 62+/-9 years) and lower ejection fraction (66+/-16% vs 73+/-8%) were associated with an increased risk for AF. Before onset, a greater number of atrial premature complexes was observed. The standard deviation of all RR intervals (SDNN) showed an increase in the group with AF in the last 15 minutes (significant vs controls and within the AF group). The low-frequency/high-frequency ratio was significantly lower in patients in the first 30 minutes, followed by an increase mainly because the high-frequency spectrum became less important. Thus, initiation of postoperative AF is influenced by autonomic tone variations. A shift in the autonomic balance with a loss of vagal tone and a moderate increase in sympathetic tone are observed before the onset of AF compared with those in controls.

Lipid Lowering Drugs and Recurrences of Life-Threatening Ventricular Arrhythmias in High-Risk Patients

OBJECTIVES To evaluate a possible effect of lipid lowering drugs on recurrences of ventricular arrhythmias (VA) after implantable cardioverter defibrillator (ICD) implantation. BACKGROUND In patients with coronary artery disease (CAD), lipid lowering drugs reduce total and sudden cardiac death. Because the mechanism is not completely understood, we studied whether these drugs have a favorable influence on the occurrence of life-threatening VA in patients with CAD and ICD implants. METHODS We conducted an observational study in 78 patients with CAD and life-threatening VA, treated with an ICD. After ICD implantation, 27 patients were on treatment with lipid lowering drugs (group I) and 51 were not (group II). Patients were studied for the following end points: recurrences of VA requiring ICD intervention, cardiac death and hospitalization. RESULTS After a mean follow-up of 490 +/- 319 days, 35 patients (45%) had recurrences of VA requiring ICD intervention. In multivariate analysis, the use of lipid lowering drugs (chi-square 6.33, p = 0.012) and poorly tolerated sustained monomorphic ventricular tachycardia as initial presentation (chi-square 4.84, p = 0.028) remained as independent predictors of recurrences of VA. Patients in groups I and II had similar baseline clinical characteristics, but patients in group I had a lower incidence of recurrences of VA (6/27 or 22% vs. 29/51 or 57%, p = 0.004) and of the combined end points of cardiac death and hospitalization (4/27 or 15% vs. 23/51 or 45%, p = 0.015) compared with patients in group II. CONCLUSIONS This is the first observation that the use of lipid lowering drugs is associated with a reduction of recurrences of VA in patients with CAD and ICD implants. These data require confirmation in a prospective randomized trial.

Development of a soil geographic database from the Soil Map of the European Communities

Abstract Questions on land use and soil conservation require increasingly accurate information on soil properties and their geographical location. Soil maps have helped to answer them thus helping in decision making. Information presented on soil maps are now managed by computer. This is the case for the Soil Map of European Communities (EC) at a scale of 1 : 1 000 000. Computerization of soil maps is often limited to soil boundaries and to the few descriptive items on the paper themselves. Much of the original survey is lost either during mapping or because it is published separately in explanatory notes or legends. This was also the case for the EC Soil Map. Many scientific publications and draft documents were used to make the original paper map, but were greatly condensed and simplified. The first version of the EC soil database is an exact copy of the paper map, thus having the same deficiencies. Using Geographical Information System technology, an efficient data structure has to be developed to take into account efficiently the internal organization of the soil cover. Such a structure should match conceptually the soil scientist review of spatial soil organization at a given scale within a computerized model. As a first step towards such a “Soil Spatial Organization Model” the material available for the compilation of the EC Soil Map is analysed. A logical data structure to receive a posteriori these informations is proposed and the databases improvement in terms of quantity as well as quality is demonstrated.

Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias

OBJECTIVE To study the outcome of patients with arrhythmogenic right ventricular dysplasia treated with an implantable cardioverter-defibrillator (ICD) for ventricular tachyarrhythmias complicated by haemodynamic collapse. DESIGN Observational study. SETTING University hospital. PATIENTS Nine consecutive patients (eight male, one female; mean (SD) age, 36 (18) years) with arrhythmogenic right ventricular dysplasia presenting with ventricular tachycardia and haemodynamic collapse (n = 6) or ventricular fibrillation (n = 3), treated with an ICD. MAIN OUTCOME MEASURES Survival; numbers of and reasons for appropriate and inappropriate ICD interventions. RESULTS After a mean (SD) follow up of 32 (24) months, all patients were alive. Six patients received a median of 19 (range 2–306) appropriate ICD interventions for events detected in the ventricular tachycardia window; four received a median of 2 (range 1–19) appropriate ICD interventions for events detected in the ventricular fibrillation window. Inappropriate interventions were seen for sinus tachycardia (18 episodes in three patients), atrial fibrillation (three episodes in one patient), and for non-sustained polymorphic ventricular tachycardia (one episode in one patient). CONCLUSIONS Patients with arrhythmogenic right ventricular dysplasia and malignant ventricular arrhythmias have a high recurrence rate requiring appropriate ICD interventions, but they also often have inappropriate interventions. Programming the device is difficult because this population develops supraventricular and ventricular tachyarrhythmias with similar rates.

Factors Influencing Long Term Persistence of Sinus Rhythm After a First Electrical Cardioversion for Atrial Fibrillation

It is conventionally thought that electrical cardioversion in patients with atrial fibrillation (AF) of longstanding duration or with a large lefi atrial diameter, only seldom results in long term success. Recurrence is common, although antiarrhythmic drugs often effectively decrease the number and duration of recurrent AF episodes. We analysed clinical, functional and pharmacological variables which could possibly infiuence the long term outcome after a first electrical cardioversion for AF in a retrospective study on 85 patients. Univariate and multivariate analysis was used to identify factors predicting maintenance of sinus rhythm at 100 days, and absence of recurrence during the entire follow‐up. In univariate analysis, the only significant predictor for maintenance of sinus rhythm at 100 days was the duration of the preceding AF episode. Multivariate analysis with persistence of sinus rhythm at 100 days as endpoint confirmed this as a prognostic factor (p <0.03), but sotalol treatment also contributed to maintenance of sinus rhythm (p <0.05). When considering ihe entire observation period, class III antiarrhythmic drugs, i.e. sotalol ami amiodarone, were useful in preventing recurrence (p <0.01 and < 0.02). High age (above 75 years) was a predictor of recurrence. In conclusion, class III antiarrhythmic drugs, the duration of atrial fibrillation and high age were the most important determirumts of long term outcome, while echocardiographic parameters and the presence of heart disease played no role.

Electrocardiographic and morphometric features in patients with ventricular tachycardia of right ventricular origin

Objective To study differences between repetitive monomorphic ventricular tachycardia (RMVT) of right ventricular origin, and ventricular tachycardia in arrhythmogenic right ventricular dysplasia (ARVD). Patients Consecutive groups with RMVT (n = 15) or ARVD (n = 12), comparable for age and function. Methods Analysis of baseline, tachycardia, and signal averaged ECGs, clinical data, and right endomyocardial biopsies. Pathological findings were related to regional depolarisation (QRS width) and repolarisation (QT interval, QT dispersion). Results There was no difference in age, ejection fraction, QRS width in leads I, V1, and V6, and QT indices. During ventricular tachycardia, more patients with ARVD had a QS wave in V1 (p < 0.05). There were significant differences for unfiltered QRS, filtered QRS, low amplitude signal duration, and the root mean square voltage content. In the absence of bundle branch block, differences became non-significant for unfiltered and filtered QRS duration. Mean (SD) percentage of biopsy surface differed between RMVT and ARVD: normal myocytes (74(3.4)% v 64.5(9.3)%; p < 0.05); fibrosis (3(1.7)% v 8.9(5.2)%; p < 0.05). When all patients were included, there were significant correlations between fibrosis and age (r = 0.6761), and fibrosis and QRS width (r = 0.5524 for lead I; r = 0.5254 for lead V1; and r = 0.6017 for lead V6). Conclusions The ECG during tachycardia and signal averaging are helpful in discriminating between ARVD and RMVT patients. There are differences in the proportions of normal myocytes and fibrosis. The QRS duration is correlated with the amount of fibrous tissue in patients with ventricular tachycardia of right ventricular origin.

Mapping and Isolation of the Pulmonary Veins Using the PVAC Catheter

Objectives: We aimed to investigate the feasibility, efficacy, and safety of the pulmonary vein ablation catheter (PVAC) catheter (a novel multielectrode catheter using duty‐cycled bipolar and unipolar radiofrequency energy, Medtronic, Minneapolis, MN, USA) to completely isolate the pulmonary veins (PVs).

Use of an Implantable Cardioverter Defibrillator in a Patient with Two Implanted Neurostimulators for Severe Parkinson's Disease

We report a patient with Parkinsons disease treated with two pectorally implanted neurostimulators (NSs) who presented with a life‐threatening ventricular tachyarrhythmia in whom an abdominal ICD was implanted. Testing during implantation showed that the NS did not affect the bipolar sensing of the ICD. even when the NSs were set at a frequency of 130 pulses/s with an output of 5 V and pulse width of 0.21 ms in a bipolar and a unipolar configuration. The ICD shock, however, did affect both NSs: there was a reset to the output Off state and there was a reset of the electrode polarities.

Duty-cycled multi-electrode radiofrequency vs. conventional irrigated point-by-point radiofrequency ablation for recurrent atrial fibrillation: comparative 3-year data

AIMS Pulmonary vein isolation (PVI) is an accepted treatment to relieve symptoms in patients with atrial fibrillation (AF). We studied 3 year outcome after PVI guided by duty-cycled multi-electrode radiofrequency (RF) ablation (pulmonary vein ablation catheter, PVAC) and provided comparative data to outcome after conventional PVI (CPVI) using mapping with irrigated, point-per-point RF ablation. METHODS AND RESULTS One hundred and sixty-one consecutive patients with symptomatic paroxysmal or persistent AF and minimal heart disease underwent PVI (PVAC, n = 79 vs. CPVI, n = 82). Follow-up (with symptom-guided rhythm monitoring) was truncated at 3 years in all patients. Success was defined as freedom of documented arrhythmia after a single procedure and without antiarrhythmic drug treatment (ADT). Baseline characteristics did not differ between both groups. At 3 years follow-up, single-procedure success without ADT was comparable between PVAC and CPVI (65% vs. 55%, P = NS). The majority of recurrences occurred during the first year (PVAC 79% vs. CPVI 70%, P = NS). The annual rate of very late recurrence (i.e. beyond 1 year) was similar in both groups (10.5% vs. 15%, P = NS). CONCLUSION At 3 years follow-up, outcome after PVAC-guided PVI is comparable to conventional isolation by irrigated point-by-point RF ablation. In both strategies, the majority of recurrences occurred in the first year of ablation.

Changes in P-wave area and P-wave duration after circumferential pulmonary vein isolation

AIMS The effect of circumferential pulmonary vein isolation (CPVI) on P-wave characteristics is not clear. We used the signal-averaged (SA) electrocardiogram (ECG) and the ECG derived vector cardiogram (dVCG) to study the influence of CPVI on P-wave duration (PWD) and P-wave area (PWA) and studied whether changes were associated with successful outcome after initial CPVI. METHODS AND RESULTS Thirty-nine patients (56 +/- 10 years, 72% males) underwent CPVI for paroxysmal or persistent atrial fibrillation (AF). For each patient, an ECG recording was taken at the start and end of the ablation procedure. dVCG was derived using the inverse Dower transform. PWD was defined by manual annotation of earliest onset and latest offset of the SA-P-wave. PWA was calculated as the area under the SA-ECG curve averaged for the 12 ECG leads (PWA-ECG) and SA-dVCG curve (PWA-dVCG). Successful outcome after CPVI was defined as freedom from symptomatic and asymptomatic AF at the end of follow-up (11 +/- 5 months). Average PWD decreased from 132 +/- 14 to 126 +/- 16 ms (P < 0.01). PWA-ECG and PWA-dVCG decreased markedly from 4.64 +/- 1.40 to 3.65 +/- 1.61 mVms (P < 0.001) and from 4.27 +/- 1.66 to 2.48 +/- 1.59 mVms (P < 0.001). Parameters of PWA were not different between successes (n = 31) and failures (n = 8). In contrast, PWD after ablation was significantly shorter in patients with successful outcome (123 +/- 16 vs. 135 +/- 11 ms, P < 0.05). CONCLUSION (i) CPVI results in a modest but significant shortening in PWD and a marked decrease in PWA. (ii) PWD was significantly shorter in cases of successful outcome after CPVI.